[Seite 116↓]

Literaturverzeichnis

Aeschbach D, Matthews JR, Postolache TT, Jackson MA, Giesen HA, Wehr TA (1997): Dynamics of the human EEG during prolonged wakefulness: evidence for frequency-specific circadian and homeostatic influences. Neurosci Lett 239: 121-124.

Agosti V and McGrath PJ (2002): Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. J Affect Disord 71: 113-120.

Agosti V and Stewart JW (2001): Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features. J Affect Disord 65: 75-79.

Akil H, Haskett RF, Young EA, Grunhaus L, Kotun J, Weinberg V, et al (1993): Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin. Biol Psychiatry 33: 73-85.

Albers HE (1981): Gonadal hormones organize and modulate the circadian system of the rat. Am J Physiol 10: R62-R66.

Almeida OF, Nikolarakis KE, Herz A (1988): Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor. Endocrinology 122: 1034-1041.

Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A (2002): Gender differences in depression Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci 252: 201-209.

Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K (2002): Toward validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord 72: 125-138.

Anisman H and Merali Z (2002): Cytokines, stress, and depressive illness. Brain Behav Immun 16: 513-524.

Anisman H, Ravindran AV, Griffiths J, Merali Z (1999a): Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4: 182-188.

Anisman H, Ravindran AV, Griffiths J, Merali Z (1999b): Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46: 1649-1655.

Antoni FA (1993): Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14: 76-122

Antonijevic IA, Murck H, Frieboes RM, Holsboer F, Steiger A (1999b): On the gender differences in sleep-endocrine regulation in young normal humans. Neuroendocrinology 70: 280-287.

Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A (1998): Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 32: 403-410.

Antonijevic IA, Murck H, Frieboes RM, Schier T, Holsboer F, Steiger A (1999a): Hyporesponsiveness of the pituitary to CRH during slow wave sleep is not mimicked by systemic GHRH. Neuroendocrinology 69: 88-96.

Antonijevic IA, Murck H, Frieboes RM, Steiger A (2000a): Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part I: the sleep EEG. Sleep Research Online 3: 5-13.


[Seite 117↓]

Antonijevic IA, Murck H, Frieboes RM, Steiger A (2000b): Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part II: hormone secretion. Sleep Research Online 3: 15-21.

Antonijevic IA, Murck H, Frieboes RM, Steiger A (2003): Sleep-endocrine correlates of atypical vs. typical depression. Biol Psychiatry (submitted).

Antonijevic IA, Murck H, Frieboes RM, Uhr M, Steiger A (2003): On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology 28: 401-418.

Antonijevic IA, Stalla GK, Steiger A (2000c): Modulation of the sleep electroencephalogram by oestrogen replacement in postmenopausal women. Am J Obstet Gynecol 182: 277-282.

Antonijevic IA and Steiger A (2003): Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology (in press).

Armitage R (1995): The distribution of EEG frequencies in REM and NREM sleep stages in healthy young adults. Sleep 18: 334-341.

Armitage R, Emslie GJ, Hoffmann RF, Rintelmann J, Rush AJ (2001): Delta sleep EEG in depressed adolescent females and healthy controls. J Affect Disord 63: 139-148.

Armitage R, Hoffmann R, Fitch T, Trivedi M, Rush AJ (2000a): Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep 23: 607-617.

Armitage R, Hoffmann R, Trivedi M, Rush AJ (2000b): Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 95: 201-213.

Asnis GM, McGinn LK, Sanderson WC (1995): Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152: 31-36.

Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Novacenko H, Ostrow LC (1981): Cortisol secretion in relation to age in major depression. Psychosom Med 43: 235-242.

Aston-Jones G and Bloom FE (1981): Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1: 876-886.

Aston-Jones G, Chen S, Zhu Y, Oshinsky ML (2001): A neural circuit for circadian regulation of arousal. Nature Neuroscience 4: 732-738.

Baldwin RC and Tomenson B (1995): Depression in later life. A comparison of symptoms and risk factors in early and late onset cases. Br J Psychiatry 167: 649-652.

Barkhudaryan N and Dunn AJ (1999): Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem Res 24: 1169-1180.

Bebbington PE, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M, et al (1998): The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity [published erratum appears in Psychol Med 1998 Sep;28(5): 1253]. Psychol Med 28: 9-19.

Bebo BFJ, Schuster JC, Vandenbark AA, Offner H (1999): Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 162: 35-40.


[Seite 118↓]

Bebo BFJ, Zelinka-Vincent E, Adamus G, Amundson D, Vandenbark AA, Offner H (1998): Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 84: 122-130.

Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992): Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49: 651-668.

Beranek L, Obál Jr. F, Bodosi B, Taishi P, Laczi F, Krueger JM (1996): Inhibition of non-REM sleep in response to a long-acting somatostatin analogue, sandostatin, in the rat. J Sleep Res 5 (Suppl. 1): 14.

Berger M, Vollmann J, Hohagen F, Konig A, Lohner H, Voderholzer U, et al (1997): Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry 154: 870-872.

Beyer HS, Matta SG, Sharp BM (1988): Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology 123: 2117-2123.

Bierwolf C, Struve K, Marshall L, Born J, Fehm HL (1997): Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. J Neuroendocrinol 9: 479-484.

Bleuer E and Bleuler M: Lehrbuch der Psychiatrie. Berlin: Springer Verlag, 1983;

Bliwise DL (1993): Sleep in normal aging and dementia. Sleep 16: 40-81.

Blurton-Jones M and Tuszynski MH (2002): Estrogen receptor-beta colocalizes extensively with parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and hippocampal formation of intact and ovariectomized adult rats. J Comp Neurol 452: 276-287.

Bohlhalter S, Murck H, Holsboer F, Steiger A (1997): Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects. Neurobiol Aging 18: 423-429.

Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, et al (2001): Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 105: 45-55.

Borbély AA (1982): A two process model of sleep regulation. Hum Neurobiol 1: 195-204.

Borbély AA, Mattmann P, Loepfe M, Strauch I, Lehmann D (1985): Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 4: 189-194.

Born J, De Kloet ER, Wenz H, Kern W, Fehm HL (1991): Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol 260: E183-E188

Born J, Ditschuneit I, Schreiber M, Dodt C, Fehm HL (1995): Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 132: 705-711.

Born J, Fehm HL (1998): Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 106: 153-163.

Born J, Hansen K, Marshall L, Molle M, Fehm HL (1999): Timing the end of nocturnal sleep. Nature 397: 29-30.

Born J, Muth S, Fehm HL (1988): The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology 13: 233-243.


[Seite 119↓]

Born J, Späth-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL (1989): Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 68: 904-911.

Born J, Steinbach D, Dodt C, Fehm HL (1997): Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab 82: 1106-1110.

Borsody MK and Weiss JM (2002): Peripheral endotoxin causes long-lasting changes in locus coeruleus activity via IL-1 in the brain. Acta Neuropsychiatrica 14: 303-321.

Brady LS (1994): Stress, antidepressant drugs, and the locus coeruleus. Brain Res Bull 35: 545-556.

Branchey M, Branchey L, Nadler RD (1971): Effects of estrogen and progesterone on sleep patterns of female rats. Physiol Behav 6: 743-746.

Brunner DP, Münch M, Biedermann K, Huch R, Huch A, Borbély AA (1994): Changes in sleep and sleep electroencephalogram during pregnancy. Sleep 17: 576-582.

Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, et al (2002): Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology 27: 470-478.

Burgess LH and Handa RJ (1992): Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131: 1261-1269.

Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990): Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10: 176-183.

Buysse DJ, Frank E, Lowe KK, Cherry CR, Kupfer DJ (1997): Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry 41: 406-418.

Buysse DJ, Hall M, Tu XM, Land S, Houck PR, Cherry CR, et al (1998): Latent structure of EEG sleep variables in depressed and control subjects: descriptions and clinical correlates. Psychiatry Res 79: 105-122.

Buysse DJ, Jarrett DB, Miewald JM, Kupfer DJ, Greenhouse JB (1990): Minute-by-minute analysis of REM sleep timing in major depression. Biol Psychiatry 28: 911-925.

Cahill L, Haier RJ, Fallon J, Alkire MT, Tang C, Keator D, et al (1996): Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proc Natl Acad Sci U S A 93: 8016-8021.

Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002): Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7: 468-473.

Casanueva FF, Burguera B, Muruais C, Dieguez C (1990): Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 70: 234-237.

Chalmers DT, Lovenberg TW, De Souza EB (1995): Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350.

Chang FC and Opp MR (2000): IL-1 is a mediator of increases in slow-wave sleep induced by CRH receptor blockade. Am J Physiol Regul Integr Comp Physiol 279: R793-R802


[Seite 120↓]

Chang FC and Opp MR (2001): Corticotropin-releasing hormone (CRH) as a regulator of waking. Neurosci Biobehav Rev 25: 445-453.

Chofflon M, Juillard C, Juillard P, Gauthier G, Grau GE (1992): Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. European Cytokine Network 3: 523-531.

Chronwall BM (1985): Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 (Suppl. 2): 1-11.

Cimini A, Bernardo A, Cifone G, Di Muzio L, Di Loreto S (2003): TNFalpha downregulates PPARdelta expression in oligodendrocyte progenitor cells: Implications for demyelinating diseases. GLIA 41: 3-14.

Clark RG, Carlsson LM, Robinson IC (1987): Growth hormone secretory profiles in conscious female rats. J Endocrinol 114: 399-407.

Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G (1984): A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 19: 1215-1228.

Commons KG, Connolley KR, Valentino RJ (2003): A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28: 206-215.

Conde GL, Bicknell RJ, Herbison AE (1995): Changing patterns of Fos expression in brainstem catecholaminergic neurons during the rat oestrous cycle. Brain Res 672: 68-76.

Copinschi G and Van Cauter E (1995): Effects of ageing on modulation of hormonal secretions by sleep and circadian rhythmicity. Horm Res 43: 20-24.

Dahabra S, Ashton CH, Bahrainian M, Britton PG, Ferrier IN, McAllister VA, et al (1998): Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression. Biol Psychiatry 44: 34-46.

Dayas CV, Buller KM, Day TA (2001): Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor. Neuroscience 105: 707-719.

Dayas CV, Xu Y, Buller KM, Day TA (2000): Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways. J Neuroendocrinol 12: 784-794.

De Kloet ER, Ratka A, Reul JMHM, Sutanto W, van Eekelen JAM (1987): Corticosteroid receptor types in brain: regulation and putative function. Ann N Y Acad Sci 512: 351-361.

De Kloet ER and Reul JM (1987): Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12: 83-105.

De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M (1998): Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269-301.

de Novaes Soares C and Almeida OP (2001): Depression during the Perimenopause. Arch Gen Psychiatry 58: 306

Del Gadillo JC, Siebzehnrubl E, Dittrich R, Wildt L, Lang N (2002): Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol 102: 179-183.


[Seite 121↓]

Del Rio G, Velardo A, Menozzi R, Zizzo G, Tavernari V, Venneri MG, et al (1998): Acute estradiol and progesterone administration reduced cardiovascular and catecholamine responses to mental stress in menopausal women. Neuroendocrinology 67: 269-274.

Deshauer D, Grof E, Alda M, Grof P (1999): Patterns of DST positivity in remitted affective disorders. Biol Psychiatry 45: 1023-1029.

Devesa J, Lima L, Tresguerres JA (1992): Neuroendocrine control of growth hormone secretion in humans. TEM 3: 175-183.

Diaz-Guerrero R, Gottlieb JS, Knott JR (1946): The sleep of patients with manic-depressive psychosis, depressed subtype. Psychosom Med 8: 399-404.

Dickinson CJ (1997): Chronic fatigue syndrome - aetiological aspects. Eur J Clin Invest 27: 257-267.

Dijk DJ (1995): EEG slow waves and sleep spindles: windows on the sleeping brain. Behav Brain Res 69: 109-116.

Dijk DJ (1999): Circadian variation of EEG power spectra in NREM and REM sleep in humans: dissociation from body temperature. J Sleep Res 8: 189-195.

Dijk DJ, Beersma DG, Bloem GM (1989): Sex differences in the sleep EEG of young adults: visual scoring and spectral analysis. Sleep 12: 500-507.

Dijk DJ and Czeisler CA (1995a): Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 15: 3526-3538.

Dijk DJ and Czeisler CA (1995b): Circadian control of the EEG in nonREM sleep. Sleep Res 24: 518

Dijk DJ and Duffy JF (1999): Circadian regulation of human sleep and age-related changes in its timing, consolidation and EEG characteristics. Ann Med 31: 130-140.

Dijk DJ, Duffy JF, Czeisler CA (2000): Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol Int 17: 285-311.

Dijk DJ, Hayes B, Czeisler CA (1993): Dynamics of electroencephalographic sleep spindles and slow wave activity in men: effect of sleep deprivation. Brain Res 626: 190-199.

Dijk DJ and Lockley SW (2002): Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol 92: 852-862.

Drevets WC (1999): Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 877: 614-637.

Driver HS, Dijk DJ, Werth E, Biedermann K, Borbély AA (1996): Sleep and the sleep electroencephalogram across the menstrual cycle in young healthy women. J Clin Endocrinol Metab 81: 728-735.

Driver HS and Shapiro CM (1992): A longitudinal study of sleep stages in young women during pregnancy and postpartum. Sleep 15: 449-453.

Eberly LB, Dudley CA, Moss RL (1983): Iontophoretic mapping of corticotropin-releasing factor (CRF) sensitive neurons in the rat forebrain. Peptides 4: 837-841.

Ehlers CL, Kaneko WM, Owens MJ, Nemeroff CB (1993): Effects of gender and social isolation on electroencephalogram and neuroendocrine parameters in rats. Biol Psychiatry 33: 358-366.

Ehlers CL and Kupfer DJ (1987): Hypothalamic peptide modulation of EEG sleep in depression: a further application of the S-process hypothesis. Biol Psychiatry 22: 513-517.


[Seite 122↓]

Ehlers CL and Kupfer DJ (1997): Slow-wave sleep: do young adult men and women age differently? J Sleep Res 6: 211-215.

Ehlers CL, Reed TK, Henriksen SJ (1986): Effects of corticotropin-releasing factor and growth hormone- releasing factor on sleep and activity in rats. Neuroendocrinology 42: 467-474.

Elenkov IJ and Chrousos GP (2002): Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966: 290-303.

Endicott J (1998): Gender similarities and differences in the course of depression. J Gend Specif Med 1: 40-43.

Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL (1981): Association of waking episodes with menopausal hot flushes. JAMA 245: 1741-1744.

Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, Connolly R, et al (2002): Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303: 1061-1066.

Esposito P, Gheorghe D, Kandere K, Pang X, Connolly R, Jacobson S, et al (2001): Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 888: 117-127.

Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, et al (1998): Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55: 66-72.

Fava M, Alpert JE, Borus JS, Nierenberg AA, Pava JA, Rosenbaum JF (1996): Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry 153: 1308-1312.

Feinstein A (2002): An examination of suicidal intent in patients with multiple sclerosis. Neurology 59: 674-678.

Feinstein A and Feinstein K (2001): Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 66: 193-198.

Ferrini M, Piroli G, Frontera M, Falbo A, Lima A, De Nicola AF (1999): Estrogens normalize the hypothalamic-pituitary-adrenal axis response to stress and increase glucocorticoid receptor immuno-reactivity in hippocampus of aging male rats. Neuroendocrinology 69: 129-137.

Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al (2002): Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8: 523-526.

Frank E, Carpenter L, Kupfer DJ (1988): Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry 145: 41-45.

Frieboes RM, Murck H, Schier T, Holsboer F, Steiger A (1997): Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology 16: 339-345.

Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R (1997): Progesterone-induced changes in sleep in male subjects. Am J Physiol 272: E885-E891

Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F (1995): DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 268: E107-E113

Friess E, von Bardeleben U, Wiedemann K, Lauer C, Holsboer F (1994): Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. J Sleep Res 3: 73-79.


[Seite 123↓]

Frodl T, Meisenzahl E, Zetzsche T, Bottlender R, Born C, Groll C, et al (2002): Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 51: 708-714.

Fumagalli F, Jones SR, Caron MG, Seidler FJ, Slotkin TA (1996): Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res 719: 225-228.

Gaillard JM and Blois R (1981): Spindle density in sleep of normal subjects. Sleep 4: 385-391.

Gais S, Molle M, Helms K, Born J (2002): Learning-dependent increases in sleep spindle density. J Neurosci 22: 6830-6834.

Gao J, Zhang JX, Xu TL (2002): Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep-waking cycle of rats. Brain Res 945: 60-70.

Garland EJ and Zis AP (1991): Multiple sclerosis and affective disorders. Can J Psychiatry 36: 112-117.

Gaudreau H, Carrier J, Montplaisir J (2001): Age-related modifications of NREM sleep EEG: from childhood to middle age. J Sleep Res 10: 165-172.

Geracioti TDJ, Loosen PT, Orth DN (1997): Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry 42: 165-174.

Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, et al (1990): Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 71: 1481-1485.

Gillin JC, Duncan WC, Murphy DL, Post RM, Wehr TA, Goodwin FK, et al (1981): Age-related changes in sleep in depressed and normal subjects. Psychiatry Res 4: 73-78.

Gold PW and Charney DS (2002): Depression: A disease of the mind, brain and body. Am J Psychiatry 159: 1826.

Gold PW and Chrousos GP (2002): Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7: 254-275.

Gold PW, Gabry KE, Yasuda MR, Chrousos GP (2002): Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am 31: 37-62.

Goldstein LE, Rasmusson AM, Bunney BS, Roth RH (1996): Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 16: 4787-4798.

Golomb D, Wang XJ, Rinzel J (1994): Synchronization properties of spindle oscillations in a thalamic reticular nucleus model. J Neurophysiol 72: 1109-1126.

Gonzalez MM and Valatx JL (1997): Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. J Sleep Res 6: 164-170.

Grasser A, Moller A, Backmund H, Yassouridis A, Holsboer F (1996): Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Experimental & Clinical Endocrinology & Diabetes 104: 31-37.


[Seite 124↓]

Grignaschi G, Sironi F, Samanin R (1996): Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor. Brain Res 708: 173-176.

Guldner J, Schier T, Friess E, Colla M, Holsboer F, Steiger A (1997): Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiol Aging 18: 491-495.

Haddad JJ, Saade NE, Safieh-Garabedian B (2002): Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol 133: 1-19.

Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS (1985): Cortisol secretion in endogenous depression. II. Time-related functions. Arch Gen Psychiatry 42: 909-914.

Handa RJ, Burgess LH, Kerr JE, O'Keefe JA (1994): Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 28: 464-476.

Hanson ES and Dallman MF (1995): Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 7: 273-279.

Harmer CJ, Rogers RD, Tunbridge E, Cowen PJ, Goodwin GM (2003): Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology 167: 417

Hartman ML, Veldhuis JD, Thorner MO (1993): Normal control of growth hormone secretion. Horm Res 40: 37-47.

Haskell SG, Richardson ED, Horwitz RI (1997): The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 50: 1249-1264.

Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA (1990): Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.

Hay AG, Bancroft J, Johnstone EC (1994): Affective symptoms in women attending a menopause clinic. Br J Psychiatry 164: 513-516.

Heilig M, Koob GF, Ekman R, Britton KT (1994): Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17: 80-85.

Heinz A, Jones DW, Bissette G, Hommer D, Ragan P, Knable M, et al (2002): Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism]. Pharmacopsychiatry 35: 127-134.

Herbison AE (1997): Estrogen regulation of GABA transmission in rat preoptic area. Brain Res Bull 44: 321-326.

Herbison AE and Fenelon VS (1995): Estrogen regulation of GABAA receptor subunit mRNA expression in preoptic area and bed nucleus of the stria terminalis of female rat brain. J Neurosci 15: 2328-2337.

Herbison AE, Heavens RP, Dyer RG (1989): Oestrogen and noradrenaline modulate endogenous GABA release from slices of the rat medial preoptic area. Brain Res 486: 195-200.

Herbison AE, Heavens RP, Dyer RG (1990): Oestrogen modulation of excitatory A1 noradrenergic input to rat medial preoptic gamma aminobutyric acid neurones demonstrated by microdialysis. Neuroendocrinology 52: 161-168.


[Seite 125↓]

Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, et al (1998): Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depression & Anxiety 8: 71-79.

Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M, et al (1994): Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging 15: 227-231.

Hiroshige T, Abe K, Wada S, Kaneko M (1973): Sex difference in circadian periodicity of CRF activity in the rat hypothalamus. Neuroendocrinology 11: 306-320.

Hiroshige T and Wada-Okada S (1973): Diurnal changes of hypothalamic content of corticotropin- releasing activity in female rats at various stages of the estrous cycle. Neuroendocrinology 12: 316-319.

Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al (1987): Effects of sex and age on the 24-hour profile of growth hormone secretion in man importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64: 51-58.

Hobson JA, McCarley RW, Wyzinski PW (1975): Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189: 55-58.

Hobson JA, Pace-Schott EF (2002): The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3: 679-693.

Hoch CC, Dew MA, Reynolds CF3, Monk TH, Buysse DJ, Houck PR, et al (1994): A longitudinal study of laboratory- and diary-based sleep measures in healthy “old old” and “young old” volunteers. Sleep 17: 489-496.

Hofman MA, Swaab DF (1993): Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8: 283-295.

Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V (1994): Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment—neurobiological and psychometric assessment of course. J Psychiatr Res 28: 381-399.

Holsboer F (1989): Psychiatric implications of altered limbic-hypothalamic- pituitary-adrenocortical activity. Eur Arch Psychiatry Neurol Sci 238: 302-322.

Holsboer F (1995): Neuroendocrinology of affective disorders. In: Neuropsychopharma-cology. 4th Generation of Progress. Bloom FE, Kupfer DJ (Eds): New York, Raven Press; 957-970.

Holsboer F (1999): The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33: 181-214.

Holsboer F (2000): The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.

Holsboer F and Barden N (1996): Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17: 187-205.

Holsboer F, Benkert O, Demisch L (1983): Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 19: 321-326.

Holsboer F, Gerken A, Steiger A, Benkert O, Muller OA, Stalla GK (1984): Corticotropin-releasing-factor induced pituitary-adrenal response in depression. Lancet 1: 55-55.


[Seite 126↓]

Holsboer F, von Bardeleben U, Steiger A (1988): Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 48: 32-38.

Holsboer F, von Bardeleben U, Wiedemann K, Muller OA, Stalla GK (1987): Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry 22: 228-234.

Huether G, Fettkotter I, Keilhoff G, Wolf G (1997): Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J Neurochem 69: 2096-2101.

Huitinga I, de Groot CJ, van d, V, Kamphorst W, Tilders FJ, Swaab DF (2001): Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 60: 1208-1218.

Huitinga I, Schmidt ED, van der Cammen MJ, Binnekade R, Tilders FJ (2000): Priming with interleukin-1beta suppresses experimental allergic encephalomyelitis in the Lewis rat. J Neuroendocrinol 12: 1186-1193.

Iovino M, Monteleone P, Steardo L (1989): Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH- releasing hormone testing in normal aging. J Clin Endocrinol Metab 69: 910-913.

Jansen AS, Schmidt ED, Voorn P, Tilders FJ (2003): Substance induced plasticity in noradrenergic innervation of the paraventricular hypothalamic nucleus. Eur J Neurosci 17: 298-306.

Jaspers K: Allgemeine Psychopathologie. Berlin: Springer Verlag, 1973;

Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD (1999): Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11: 465-471.

Jindal RD, Thase ME, Fasiczka AL, Friedman ES, Buysse DJ, Frank E, et al (2002): Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission. Biol Psychiatry 51: 230-236.

Jones DNC, Kortekaas R, Slade PD, Middlemiss DN, Hagan JJ (1998): The behavioural effects of corticotropin releasing factor related peptides in rats. Psychopharmacology 138: 124-132.

Juhasz G, Emri Z, Kekesi KA, Salfay O, Crunelli V (1994): Blockade of thalamic GABAB receptors decreases EEG synchronization. Neurosci Lett 172: 155-158.

Karanth S, Linthorst AC, Stalla GK, Barden N, Holsboer F, Reul JM (1997): Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 138: 3476-3485.

Kasckow JW, Regmi A, Gill PS, Parkes DG, Geracioti TD (1997): Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures. Endocrinology 138: 4774-4782.

Keck ME, Welt T, Müller MB, Uhr M, Ohl F, Wigger A, et al (2003): Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28: 235-243.


[Seite 127↓]

Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul JM, et al (2002): Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26: 94-105.

Kenis G and Maes M (2002): Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5: 401-412.

Kerkhofs M, Kempenaers C, Linkowski P, de M, V, Mendlewicz J (1988): Multivariate study of sleep EEG in depression. Acta Psychiatr Scand 77: 463-468.

Kerkhofs M, Van Cauter E, Thorner MO, Copinschi G: Growth hormone (GH), GH-releasing hormone (GHRH), GH-releasing peptide (GHRP) and sleep in man. J.Sleep Res. 1996; 5 (Suppl. 1): 107(Abstract)

Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G (1993): Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 264: E594-E598

Kern W, Halder R, al-Reda S, Späth-Schwalbe E, Fehm HL, Born J (1993): Systemic growth hormone does not affect human sleep. J Clin Endocrinol Metab 76: 1428-1432.

Khan AA, Gardner CO, Prescott CA, Kendler KS (2002): Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs. Am J Psychiatry 159: 1427-1429.

Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR (1999): Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52: 1230-1238.

Kim S and Voskuhl RR (1999): Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 162: 5561-5568.

Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979): Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36: 550-554.

Klein DN, Schatzberg AF, McCullough JP, Dowling F, Goodman D, Howland RH, et al (1999): Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord 55: 149-157.

Klink R, Robichaud M, Debonnel G (2002): Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part II. Regulatory mechanisms. Neuropharmacology 43: 1129-1138.

Kockler M and Heun R (2002): Gender differences of depressive symptoms in depressed and nondepressed elderly persons. Int J Geriatr Psychiatry 17: 65-72.

Konsman JP, Parnet P, Dantzer R (2002): Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25: 154-159.

Korf J, Klein HC, Versijpt J, den Boer JA, ter Horst GJ (2002): Considering depression as a consequence of activation of the inflammatory response system. Acta Neuropsychiatrica 14: 1-10.

Kornstein SG (2001): The evaluation and management of depression in women across the life span. J Clin Psychiatry 62 Suppl 24: 11-17.

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al (2000a): Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157: 1445-1452.


[Seite 128↓]

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al (2000b): Gender differences in chronic major and double depression. J Affect Disord 60: 1-11.

Krieg JC, Lauer CJ, Schreiber W, Modell S, Holsboer F (2001): Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'. J Affect Disord 62: 33-37.

Kronfol Z and Remick DG (2000): Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:

Krueger JM and Obál Jr. F (1993): Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J 7: 645-652.

Kruijver FP, Swaab DF (2002): Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology 75: 296-305.

Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001): Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21: 199-206.

Kupfer DJ (1995): Sleep research in depressive illness: clinical implications - a tasting menu. Biol Psychiatry 38: 391-403.

Kupfer DJ and Foster G (1972): Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 2: 684-686.

Kupfer DJ, Frank E, McEachran AB, Grochocinski VJ (1990): Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 47: 1100-1105.

Kupfer DJ, Jarrett DB, Ehlers CL (1991): The effect of GRF on the EEG sleep of normal males. Sleep 14: 87-88.

Kupfer DJ, Jarrett DB, Ehlers CL (1992): The effect of SRIF on the EEG sleep of normal men. Psychoneuroendocrinology 17: 37-43.

Kupfer DJ, Reynolds CF3, Ulrich RF, Shaw DH, Coble PA (1982): EEG sleep, depression, and aging. Neurobiol Aging 3: 351-360.

Kushikata T, Fang J, Krueger JM (1999): Interleukin-10 inhibits spontaneous sleep in rabbits. Journal of Interferon & Cytokine Research 19: 1025-1030.

Lalive PH, Burkhard PR, Chofflon M (2002): TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse. Behav Neurosci 116: 1093-1097.

Lancel M (1999): Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22: 33-42.

Lancel M, Crönlein TA, Faulhaber J (1996c): Role of GABAA receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 15: 63-74.

Lancel M, Faulhaber J, Deisz RA (1998): Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br J Pharmacol 123: 1471-1477.

Lancel M, Faulhaber J, Holsboer F, Rupprecht R (1996a): Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol 271: E763-E772

Lancel M, Mathias S, Faulhaber J, Schiffelholz T (1996b): Effect of interleukin-1 beta on EEG power density during sleep depends on circadian phase. Am J Physiol 270: R830-R837


[Seite 129↓]

Lancel M, Van Riezen H, Glatt A (1992): The time course of sigma activity and slow-wave activity during NREMS in cortical and thalamic EEG of the cat during baseline and after 12 hours of wakefulness. Brain Res 596: 285-295.

Landolt HP, Dijk DJ, Achermann P, Borbély AA (1996): Effect of age on the sleep EEG: slow-wave activity and spindle frequency activity in young and middle-aged men. Brain Res 738: 205-212.

Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ H (1987): Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab 65: 535-540.

Larsen PJ, Moller M, Mikkelsen JD (1991): Efferent projections from the periventricular and medial parvicellular subnuclei of the hypothalamic paraventricular nucleus to circumventricular organs of the rat: a Phaseolus vulgaris-leucoagglutinin (PHA-L) tracing study. J Comp Neurol 306: 462-479.

Lauer CJ, Riemann D, Wiegand M, Berger M (1991): From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 29: 979-993.

Lechner SM and Valentino RJ (1999): Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus. Brain Res 816: 17-28.

Lee JH, Reynolds CF3, Hoch CC, Buysse DJ, Mazumdar S, George CJ, et al (1993): Electroencephalographic sleep in recently remitted, elderly depressed patients in double-blind placebo-maintenance therapy. Neuropsychopharmacology 8: 143-150.

Legoratti-Sanchez MO, Guevara-Guzman R, Solano-Flores LP (1989): Electrophysiological evidence of a bidirectional communication between the locus coeruleus and the suprachiasmatic nucleus. Brain Res Bull 23: 283-288.

Leibenluft E (1993): Do gonadal steroids regulate circadian rhythms in humans? J Affect Disord 29: 175-181.

Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE (2003): Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology 28: 119-125.

Leonard BE (2001): The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 25: 767-780.

Lesch KP, Widerlöv E, Ekman R, Laux G, Rupprecht R, Schulte HM, et al (1989): The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls. J Neural Transm 75: 111-118.

Levic Z, Micic D, Nikolic J, Stojisavljevic N, Sokic D, Jankovic S, et al (1996): Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. J Endocrinol Invest 19: 30-34.

Levine S and Saltzman A (1987): Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain, Behavior, & Immunity 1: 336-341.

Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH (2002): Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 27: 47-51.

Liberzon I, Lopez JF, Flagel SB, Vazquez DM, Young EA (1999): Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. J Neuroendocrinol 11: 11-17.


[Seite 130↓]

Lin A, Song C, Kenis G, Bosmans E, De Jongh R, Scharpe S, et al (2000): The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J Affect Disord 58: 69-74.

Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, et al (1987): 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 65: 141-152.

Linthorst AC, Penalva RG, Flachskamm C, Holsboer F, Reul JM (2002): Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 16: 2441-2452.

Loomis AL, Harvey EN, Hobart G (2002): Potential rhythms of the cortex during sleep. Science 81: 597-598.

Lu NZ and Bethea CL (2002): Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27: 12-24.

Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, et al (1999): Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Reviews in the Neurosciences 10: 117-139.

Maes M (2001): The immunoregulatory effects of antidepressants. Hum Psychopharmacol 16: 95-103.

Maes M (2002): Effects of age and gender on the classification and phenomenology of unipolar depression. Acta Neuropsychiatrica 14: 29-35.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997): Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9: 853-858.

Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al (1995): Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34: 301-309.

Maes M, Meltzer HY, D'Hondt P, Cosyns P, Blockx P (1995): Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology 20: 149-167.

Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E (2001): The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 63: 85-92.

Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S (2001): Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med 31: 847-858.

Maes M, Scharpe S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, et al (1994): Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 54: 143-160.

Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, et al (1999): Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20: 370-379.


[Seite 131↓]

Makino S, Gold PW, Schulkin J (1994): Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640: 105-112.

Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, et al (1998): Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44: 1090-1098.

Man MS, Young AH, McAllister-Williams RH (2002): Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice. J Psychopharmacol 16: 245-252.

Manber R and Armitage R (1999): Sex, steroids, and sleep: a review. Sleep 22: 540-555.

Marrosu F, Gessa GL, Giagheddu M, Fratta W (1990): Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res 515: 315-318.

Marshall L, Mölle M, Böschen G, Steiger A, Fehm HL, Born J (1996): Greater efficacy of episodic than continuous growth hormone releasing hormone (GHRH) administration in promoting slow wave sleep (SWS). J Clin Endocrinol Metab 81: 1009-1013.

Matsushima M (1990): Intracerebral sites of action of estrogen on the sleep- wakefulness circadian rhythm in female rats. Fukuoka Igaku Zasshi 81: 48-67.

Matsushima M and Takeichi M (1990): Effects of intraventricular implantation of crystalline estradiol benzoate on the sleep-wakefulness circadian rhythm of ovariectomized rats. Jpn J Psychiatry Neurol 44: 111-121.

Mayberg H (2002): Depression, II: Localization of Pathophysiology. Am J Psychiatry 159: 1979.

Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al (2002): The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728-737.

McCann SM, Licinio J, Wong ML, Yu WH, Karanth S, Rettorri V (1998): The nitric oxide hypothesis of aging. Exp Gerontol 33: 813-826.

McCarley RW and Hobson JA (1975): Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 189: 58-60.

McCarthy JR, Heinrichs SC, Grigoriadis DE (1999): Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 5: 289-315.

McEwen B (2002): Estrogen actions throughout the brain. Recent Prog Horm Res 57: 357-384.

McEwen BS, Gould E, Orchinik M, Weiland NG, Woolley CS (1995): Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes. Ciba Found Symp 191: 52-73.

McGaugh JL, Cahill L, Roozendaal B (1996): Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci U S A 93: 13508-13514.

McGinn LK, Asnis GM, Rubinson E (1996): Biological and clinical validation of atypical depression. Psychiatry Res 60: 191-198.

McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, et al (1992): Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 12: 197-202.


[Seite 132↓]

McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF (2000): A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry 157: 344-350.

Meister B and Hökfelt T (1988): Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 2: 585-605.

Mello LE, Tan AM, Finch DM (1992a): Convergence of projections from the rat hippocampal formation, medial geniculate and basal forebrain onto single amygdaloid neurons: an in vivo extra- and intracellular electrophysiological study. Brain Res 587: 24-40.

Mello LE, Tan AM, Finch DM (1992b): GABAergic synaptic transmission in projections from the basal forebrain and hippocampal formation to the amygdala: an in vivo iontophoretic study. Brain Res 587: 41-48.

Mendelson WB, Slater S, Gold P, Gillin JC (1980): The effect of growth hormone administration on human sleep: a dose-response study. Biol Psychiatry 15: 613-618.

Merali Z, McIntosh J, Kent P, Michaud D, Anisman H (1998): Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18: 4758-4766.

Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al (1994): Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 79: 848-853.

Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001): Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11: 203-208.

Mirmiran M, Koster-Van Hoffen GC, Bos NPA (1995): Circadian rhythm generation in the cultured suprachiasmatic nucleus. Brain Res Bull 38: 275-283.

Mirmiran M, Swaab DF, Kok JH, Hofman MA, Van Witting W, Gool WA (1992): Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res 93: 151-163.

Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F (1998): Hormonal response pattern in the combinded Dex-CRH test is stable over time in subjects at high familial risk for affective disorder. Neuropsychopharmacology 18: 253-262.

Modell S, Yassouridis A, Huber J, Holsboer F (1997): Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65: 216-222.

Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP (2001): Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch Neurol 58: 1081-1086.

Mulder AB, Hodenpijl MG, Lopes dSF (1998): Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci 18: 5095-5102.

Mullington J, Korth C, Hermann DM, Orth A, Galanos C, Holsboer F, et al (2000): Dose-dependent effects of endotoxin on human sleep. Am J Physiol 278: R947-R955

Murck H (2002): Atypical depression and related disorders - neurobiology and treatment with hypericum extract. Wien Med Wochenschr 152: 398-403.

Murck H, Antonijevic IA, Schier T, Frieboes RM, Barthelmes J, Steiger A (1999): Aging does not affect the sleep endocrine response to total sleep deprivation in humans. Neurobiol Aging 20: 665-668.


[Seite 133↓]

Murck H, Frieboes RM, Antonijevic IA, Steiger A (2001): Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD68843 on the sleep EEG in healthy men. Psychopharmacology 155: 187-192.

Murck H, Nickel T, Künzel H, Antonijevic IA, Schill J, Zobel A, et al (2003): State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 28: 348-358.

Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al (2001): Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158: 1252-1257.

Nemeroff CB (1988): The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 21: 76-82.

Nibuya M, Nestler EJ, Duman RS (1996): Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365-2372.

Nierenberg AA, Pava JA, Clancy K, Rosenbaum JF, Fava M (1996): Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry 40: 691-696.

Nitz D and Siegel JM (1997): GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience 78: 795-801.

Nofzinger EA, Buysse DJ, Miewald JM, Meltzer CC, Price JC, Sembrat RC, et al (2002): Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain 125: 1105-1115.

Norbury R, Cutter WJ, Compton J, Robertson DM, Craig M, Whitehead M, et al (2003): The neuroprotective effects of estrogen on the aging brain. Exp Gerontol 38: 109-117.

Nunez A, Curró Dossi R, Contreras D, Steriade M (1992): Intracellular evidence for incompatibility between spindle and delta oscillations in thalamocortical neurons of cat. Neuroscience 48: 75-85.

Obál Jr. F, Alföldi P, Cady AB, Johannsen L, Sary G, Krueger JM (1988): Growth hormone-releasing factor enhances sleep in rats and rabbits. Am J Physiol 255: R310-R316

Obál Jr. F, Floyd R, Kapás L, Bodosi B, Krueger JM (1996): Effects of systemic GHRH on sleep in intact and in hypophysectomized rats. Am J Physiol 270: E230-E237

Obál Jr. F, Opp M, Sary G, Krueger JM (1990): Endocrine mechanisms in sleep regulation. In: Endogenous sleep factors. Inoué S, Krueger JM (Eds): The Hague , SPB Academic Publishing; 109-120.

Obál Jr. F, Payne L, Kapás L, Opp M, Krueger JM (1991): Inhibition of growth hormone-releasing factor suppresses both sleep and growth hormone secretion in the rat. Brain Res 557: 149-153.

Obál Jr. F, Payne L, Opp M, Alföldi P, Kapás L, Krueger JM (1992): Growth hormone-releasing hormone antibodies suppress sleep and prevent enhancement of sleep after sleep deprivation. Am J Physiol 263: R1078-R1085.

Opp M, Obál Jr. F, Krueger JM (1989): Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257: R528-R535.

Opp MR (1995): Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 5: 127-143.


[Seite 134↓]

Opp MR and Imeri L (2001): Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1. Neuroendocrinology 73: 272-284.

Opp MR, Smith EM, Hughes TK, Jr. (1995): Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. Journal of Neuroimmunology 60: 165-168.

Otake K and Nakamura Y (1995): Sites of origin of corticotropin-releasing factor-like immunoreactive projection fibers to the paraventricular thalamic nucleus in the rat. Neurosci Lett 201: 84-86.

Owen BM, Eccleston D, Ferrier IN, Young AH (2001): Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103: 226-228.

Owens MJ and Nemeroff CB (1993): The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp 172: 296-308.

Pace-Schott EF and Hobson JA (2002): The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3: 591-605.

Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D (2002): Atypical depression: a reappraisal. Am J Psychiatry 159: 1470-1479.

Parry BL (1989): Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12: 207-220.

Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, et al (2002): Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954: 173-182.

Paul SM, Purdy RH (1992): Neuroactive steroids. FASEB J 6: 2311-2322.

Payne LC, Obal FJ, Krueger JM (1993): Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J Cell Biochem 53: 309-313.

Pearlstein T, Rosen K, Stone AB (1997): Mood disorders and menopause. Endocrinol Metab Clin North Am 26: 279-294.

Pearlstein TB (1995): Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 173: 646-653.

Perras B, Pannenborg H, Marshall L, Pietrowsky R, Born, Lorenz FH (1999): Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin. J Clin Psychopharmacol 19: 28-36.

Poland RE, McCracken JT, Lutchmansingh P, Tondo L (1992): Relationship between REM sleep latency and nocturnal cortisol concentrations in depressed patients. J Sleep Res 1: 54-57.

Pollmächer T, Haack M, Schuld A, Reichenberg A, Yirmiya R (2002): Low levels of circulating inflammatory cytokines-Do they affect human brain functions? Brain Behav Immun 16: 525-532.

Pollmächer T and Lauer CJ (1992): Physiologie von Schlaf und Schlafregulation. In: Handbuch des normalen und gestörten Schlafes. Berger M, ed. Berlin: Spinger Verlag,1-44.

Prolo P and Licinio J (1999): Cytokines in affective disorders and schizophrenia: new clinical and genetic findings. Mol Psychiatry 4: 109-111.


[Seite 135↓]

Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, et al (1990): Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Arch Gen Psychiatry 47: 935-941.

Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Davies M, et al (1985): Sleep of atypical depressives. J Affect Disord 8: 61-67.

Quitkin FM, Stewart JW, McGrath PJ, Nunes EV, Klein DF (1997): The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 54: 970-972.

Quitkin FM, Stewart JW, McGrath PJ, Taylor BP, Tisminetzky MS, Petkova E, et al (2002): Are There Differences Between Women's and Men's Antidepressant Responses? Am J Psychiatry 159: 1848-1854.

Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, et al (1993): Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl 21: 30-34.

Raber J, Chen S, Mucke L, Feng L (1997): Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. J Biol Chem 272: 15057-15060.

Rechtschaffen A and Kales A (1968): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: US Department of Health, Education & Welfare, Neurological Information Network.

Redei E, Li L, Halasz I, McGivern RF, Aird F (1994): Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: effect of chronic estrogen and progesterone. Neuroendocrinology 60: 113-123.

Reul JM and Holsboer F (2002): Corticotropin-releasing factor receptors 1 and2 in anxiety and depression. Curr Opin Pharmacol 2: 23-33.

Reynolds CF, Buysse DJ, Brunner DP, Begley AE, Dew MA, Hoch CC, et al (1997): Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation. Biol Psychiatry 42: 560-567.

Reynolds CF, Kupfer DJ, Houck PR, Hoch CC, Stack JA, Berman SR, et al (1988): Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data. Arch Gen Psychiatry 45: 258-264.

Reynolds CF, Kupfer DJ, Thase ME, Frank E, Jarrett DB, Coble PA, et al (1990): Sleep, gender, and depression: an analysis of gender effects on the electroencephalographic sleep of302 depressed outpatients. Biol Psychiatry 28: 673-684.

Riemann D, Berger M, Voderholzer U (2001): Sleep and depression--results from psychobiological studies: an overview. Biol Psychol 57: 67-103.

Riemann D, Konig A, Hohagen F, Kiemen A, Voderholzer U, Backhaus J, et al (1999): How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay. Eur Arch Psychiatry Clin Neurosci 249: 231-237.

Riise T and Lund A (2001): Prognostic factors in major depression: a long-term follow-up study of323 patients. J Affect Disord 65: 297-306.

Rivier C and Rivest S (1991): Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biology of Reproduction 45: 523-532.


[Seite 136↓]

Rivier C and Vale W (1984): Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology 114: 2409-2411.

Roozendaal B (2000): Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25: 213-238.

Roozendaal B and McGaugh JL (1996): Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiology of Learning & Memory 65: 1-8.

Roozendaal B, Quirarte GL, McGaugh JL (1997): Stress-activated hormonal systems and the regulation of memory storage. Ann N Y Acad Sci 821: 247-258.

Roozendaal B, Williams CL, McGaugh JL (1999): Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala. Eur J Neurosci 11: 1317-1323.

Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al (2001a): Inflammatory markers in major depression and melancholia. J Affect Disord 63: 93-102.

Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H (2001b): Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 251: 90-97.

Rothuizen J, Reul JM, Van Sluijs FJ, Mol JA, Rijnberk A, De Kloet ER (1993): Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs. Endocrinology 132: 161-168.

Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL (1987): Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 44: 328-336.

Rubin RT, Poland RE, Rubin LE, Gouin PR (1974): The neuroendocrinology of human sleep. Life Sci 14: 1041-1052.

Rupprecht R, Berning B, Hauser CA, Holsboer F, Reul JM (1996a): Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship. Eur J Pharmacol 303: 227-234.

Rupprecht R, Hauser CA, Trapp T, Holsboer F (1996b): Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol 56: 163-168.

Saletu B, Brandstatter N, Metka M, Stamenkovic M, Anderer P, Semlitsch, et al (1996): Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls. Maturitas 23: 91-105.

Salzarulo P, Formicola G, Lombardo P, Gori S, Rossi L, Murri L, et al (1997): Functional uncertainty, aging and memory processes during sleep. Acta Neurol Belg 97: 118-122.

Sapolsky RM (1987): Glucocorticoids and hippocampal damage. Trends Neurosci 10: 346-349.

Scharf MB, McDannold MD, Stover R, Zaretsky N, Berkowitz DV (1997): Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot study. Clin Ther 19: 304-311.

Schiffer RB, Caine ED, Bamford KA, Levy S (1983): Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 140: 1498-1500.


[Seite 137↓]

Schittecatte M, Charles G, Machowski R, Dumont F, Garcia-Valentin J, Wilmotte J, et al (1994): Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter study. Am J Psychiatry 151: 216-220.

Schöbitz B, Reul JM, Holsboer F (1994a): The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. Critical Reviews in Neurobiology 8: 263-291.

Schöbitz B, Sutanto W, Carey MP, Holsboer F, De Kloet ER (1994b): Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 60: 124-133.

Schmidt ED, Schoffelmeer AN, De Vries TJ, Wardeh G, Dogterom G, Bol JG, et al (2001): A single administration of interleukin-1 or amphetamine induces long-lasting increases in evoked noradrenaline release in the hypothalamus and sensitization of ACTH and corticosterone responses in rats. Eur J Neurosci 13: 1923-1930.

Schmidt PJ, Roca CA, Rubinow DR (1998): Clinical evaluation in studies of perimenopausal women: position paper. Psychopharmacol Bull 34: 309-311.

Schulz H and Salzarulo P (1997): The relationship between sleep and cognitive functions during wakefulness: an introduction. Acta Neurol Belg 97: 93-95.

Schumann EM, Kumpfel T, Then Berg F, Trenkwalder C, Holsboer F, Auer DP (2002): Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol 51: 763-767.

Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG (1996): Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98: 1101-1106.

Schwartz S, Maquet P, Frith C (2002): Neural correlates of perceptual learning: a functional MRI study of visual texture discrimination. Proc Natl Acad Sci U S A 99: 17137-17142.

Scott LV and Dinan TG (1998): Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression. Life Sci 62: 1985-1998.

Seeman TE, Singer B, Charpentier P (1995): Gender differences in patterns of HPA axis response to challenge: Macarthur studies of successful aging. Psychoneuroendocrinology 20: 711-725.

Sharief MK and Thompson EJ (1993): Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. J Neurol Neurosurg Psychiatry 56: 169-174.

Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999): Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034-5043.

Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996): Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908-3913.

Shepard JD, Barron KW, Myers DA (2003): Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 963: 203-213.

Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, et al (1984): Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 58: 212-214.


[Seite 138↓]

Silverstein B (2002): Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 159: 1051-1052.

Sirinathsinghji DJ, Rees LH, Rivier J, Vale W (1983): Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 305: 232-235.

Slotkin TA, McCook EC, Ritchie JC, Carroll BJ, Seidler FJ (1997): Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry 41: 172-183.

Smith C (1996): Sleep states, memory processes and synaptic plasticity. Behav Brain Res 78: 49-56.

Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TKJ (1999): IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 100: 140-148.

Soares CN, Poitras JR, Prouty J (2003): Effect of Reproductive Hormones and Selective Estrogen Receptor Modulators on Mood during Menopause. Drugs Aging 20: 85-100.

Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, et al (1998): The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49: 211-219.

Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B (1989): Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 28: 263-278.

Späth-Schwalbe E, Uthgenannt D, Voget G, Kern W, Born J, Fehm HL (1993): Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab 77: 1170-1173.

Spiegel R, Herzog A, Köberle S (1999): Polygraphic sleep criteria as predictors of successful aging: an exploratory longitudinal study. Biol Psychiatry 45: 435-442.

Stahl SM (1998): Mechanism of action of serotonin selective reuptake inhibitors – Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51: 215-235.

Stefos G, Staner L, Kerkhofs M, Hubain P, Mendlewicz J, Linkowski P (1998): Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study. Biol Psychiatry 44: 1314-1320.

Steiger A (1996): Depression und Schlaf. Jatros Neurologie 12 (Suppl.) : 19-26.

Steiger A (1997): Die Effekte antidepressiver Medikation auf den Schlaf affektiv erkrankter Patienten. In: Kompendium Schlafmedizin für Ausbildung, Klinik und Praxis. Deutsche Gesellschaft für Schlafforschung und Schlafmedizin. Schulz H (Ed): Landsberg, Ecomed.

Steiger A, Antonijevic IA, Bohlhalter S, Frieboes RM, Friess E, Murck H (1998): Effects of hormones on sleep. Horm Res 49: 125-130.

Steiger A, Guldner J, Colla-Müller M, Friess E, Sonntag A, Schier T (1994): Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression. J Psychiatr Res 28: 225-238.

Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F (1992): Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56: 566-573.

Steiger A and Holsboer F (1997): Neuropeptides and human sleep. Sleep 20: 1038-1052.


[Seite 139↓]

Steiger A, von Bardeleben U, Herth T, Holsboer F (1989): Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord 16: 189-195.

Stejskal J and Stejskal VD (1999): The role of metals in autoimmunity and the link to neuroendocrinology. Neuroendocrinol Lett 20: 351-364.

Steriade M (1994): Sleep oscillations and their blockage by activating systems. J Psychiatry Neurosci 19: 354-358.

Steriade M, Dossi RC, Nunez A (1991): Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves: cortically induced synchronization and brainstem cholinergic suppression. J Neurosci 11: 3200-3217.

Stewart JW, Garfinkel R, Nunes EV, Donovan S, Klein DF (1998): Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 18: 429-434.

Stewart JW, McGrath PJ, Quitkin FM (2002): Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features? Neuropsychopharmacology 26: 237-245.

Stickgold R (2001): Watching the sleeping brain watch us - sensory processing during sleep. Trends Neurosci 24: 307-309.

Stickgold R, Fosse R, Walker MP (2002): Linking brain and behavior in sleep-dependent learning and memory consolidation. Proc Natl Acad Sci U S A 99: 16519-16521.

Stickgold R, James L, Hobson JA (2000): Visual discrimination learning requires sleep after training. Nat Neurosci 3: 1237-1238.

Sullivan PF, Prescott CA, Kendler KS (2002): The subtypes of major depression in a twin registry. J Affect Disord 68: 273-284.

Sumová A, Trávnícková Z, Peters R, Schwartz WJ, Illnerová H (1995): The rat suprachiasmatic nucleus is a clock for all seasons. Proc Natl Acad Sci USA 92: 7754-7758.

Svendsen K and Christensen PG (1981): Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report. Acta Psychiatr Scand 64: 238-243.

Swaab DF (1995): Ageing of the human hypothalamus. Horm Res 43: 8-11.

Takahashi T, Okimura Y, Yoshimura K, Shigeyoshi Y, Kaji H, Abe H, et al (1995): Regional distribution of growth hormone-releasing hormone (GHRH) receptor mRNA in the rat brain. Endocrinology 136: 4721-4724.

Thase ME (1998): Depression, sleep, and antidepressants. J Clin Psychiat 59 Suppl 4: 55-65.

Thase ME, Carpenter L, Kupfer DJ, Frank E (1991): Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull 27: 17-22.

Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E (1997): Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry 41: 964-973.

Then Bergh F, Grasser A, Trenkwalder C, Backmund H, Holsboer F, Rupprecht R (1999a): Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. Journal of Neurology 246: 292-298.


[Seite 140↓]

Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F (1999b): Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53: 772-777.

Thomas E, Pernar L, Lucki I, Valentino RJ (2003): Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons. Brain Res 960: 201-208.

Thomson J and Oswald I (1977): Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. Br Med J 2: 1317-1319.

Tilders FJ, Schmidt ED, Hoogendijk WJ, Swaab DF (1999): Delayed effects of stress and immune activation. Baillieres Best Pract Res Clin Endocrinol Metab 13: 523-540.

Tomaszuk A, Simpson C, Williams G (1996): Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 46: 53-58.

Torres G, Horowitz JM, Laflamme N, Rivest S (1998): Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain. Neuroscience 87: 463-477.

Tsigos C and Chrousos GP (2002): Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53: 865-871.

Turner BB (1997): Influence of gonadal steroids on brain corticosteroid receptors: a minireview. Neurochem Res 22: 1375-1385.

Turner JP and Tannenbaum GS (1995): In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion. Am J Physiol 269: E683-E690

Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS (1996): Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. J Clin Endocrinol Metab 81: 2487-2494.

Valentino RJ (1988): CRH effects on central noradrenergic neurons: relationship to stress. Adv Exp Med Biol 245: 47-64.

Valentino RJ, Foote SL, Aston-Jones G (1983): Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270: 363-367.

Valentino RJ, Foote SL, Page ME (1993): The locus coeruleus as a site for integrating corticotropin- releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 697: 173-188.

Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G (1992): A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 74: 1441-1450.

Van Cauter E, Leproult R, Kupfer DJ (1996): Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81: 2468-2473.

Van Cauter E, Leproult R, Plat L (2000): Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 284: 861-868.

Van Cauter E, Plat L, Copinschi G (1998): Interrelations between sleep and the somatotropic axis. Sleep 21: 553-566.

Van Coevorden A, Mockel J, Laurent E, Kerkhofs M, L'Hermite-Balériaux M, Decoster C, et al (1991): Neuroendocrine rhythms and sleep in aging men. Am J Physiol 260: E651-E661


[Seite 141↓]

van Gaalen MM, Stenzel-Poore MP, Holsboer F, Steckler T (2002): Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 15: 2007-2015.

Van Someren EJ (2000): More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol Int 17: 313-354.

Vgontzas AN and Chrousos GP (2002): Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 31: 15-36.

Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, et al (1999): Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84: 2603-2607.

Voskuhl RR and Palaszynski K (2001): Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7: 258-270.

Vrang N, Larsen PJ, Mikkelsen JD (1995): Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated by means of Phaseolus vulgaris-leucoagglutinin tract tracing. Brain Res 684: 61-69.

Wager S, Robinson D, Goetz R, Nunes E, Gully R, Quitkin F (1990): Cholinergic REM sleep induction in atypical depression. Biol Psychiatry 27: 441-446.

Wagner U, Gais S, Born J (2001): Emotional memory formation is enhanced across sleep intervals with high amounts of rapid eye movement sleep. Learn Mem 8: 112-119.

Walker MP, Liston C, Hobson JA, Stickgold R (2002): Cognitive flexibility across the sleep-wake cycle: REM-sleep enhancement of anagram problem solving. Brain Res Cogn Brain Res 14: 317-324.

Wang XJ and Rinzel J (1993): Spindle rhythmicity in the reticularis thalami nucleus: synchronization among mutually inhibitory neurons. Neuroscience 53: 899-904.

Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA (1997): Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272: 9287-9293.

Wehr TA, Muscettola G, Goodwin FK (1980): Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects. Arch Gen Psychiatry 37: 257-263.

Wehr TA and Wirz-Justice A (1982): Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria 15: 31-39.

Weidenfeld J, Itzik A, Feldman S (1997): Effect of glucocorticoids on the adrenocortical axis responses to electrical stimulation of the amygdala and the ventral noradrenergic bundle. Brain Res 754: 187-194.

Weidenfeld J, Newman ME, Itzik A, Gur E, Feldman S (2002): The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic serotonin following electrical stimulation of the dorsal raphe nucleus in the rat. Neuroendocrinology 76: 63-69.

Weindl A (1973): Neuroendocrine aspects of circumventricular organs. In: Frontiers in Neuroendocrinology, 1973. Ganong WF, Martini L (Eds): New York, Oxford University Press; 3-32.

Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J (1983): Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 56: 352-358.


[Seite 142↓]

Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H (1994): Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry 35: 42-47.

Wever RA (1984): Sex differences in human circadian rhythms: intrinsic periods and sleep fractions. Experientia 40: 1226-1234.

Whitacre CC (2001): Sex differences in autoimmune disease. Nat Immunol 2: 777-780.

Whitacre CC, Dowdell K, Griffin AC (1998): Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 840: 705-716.

Whitacre CC, Reingold SC, O'Looney PA (1999): A gender gap in autoimmunity. Science 283: 1277-1278.

Williams R, Karacan J, Hursch C (1974): Electroencephalography of Human Sleep - Clinical Applications. New York: J. Wiley.

Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, et al (2000): Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci 97: 325-330.

Wong ML, Licinio J, Pasternak KI, Gold PW (1994): Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 135: 2275-2278.

Wyatt RJ, Fram DH, Kupfer DJ, Snyder F (1971): Total prolonged drug-induced REM sleep suppression in anxious- depressed patients. Arch Gen Psychiatry 24: 145-155.

Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003): Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60: 24-28.

Zafeiriou S, Loutradis D, Michalas S (2000): The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction. Eur J Contracept Reprod Health Care 5: 157-167.

Zaharia MD, Ravindran AV, Griffiths J, Merali Z, Anisman H (2000): Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J Affect Disord 58: 1-10.

Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001): Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 35: 83-94.

Zobel AW, Yassouridis A, Frieboes RM, Holsboer F (1999): Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 156: 949-951.

Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al (2001): Depression and anxiety in multiple sclerosis. A clinical and MRI study in95 subjects. J Neurol 248: 416-421.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
02.06.2005